Home
Contacts
Program Description
FP7 Grant
Consortium
Orphan drug
ARDS
News
News
8.5. 2018
Faron announces top line data from the Phase III INTEREST trial with Traumakine in the treatment of ARDS
11.12. 2017
Recruitment completed in Traumakine INTEREST Trial
29.12. 2015
First Patient recruited in Pan-European Phase III INTEREST study for treatment of acute respiratory distress syndrome
4.2. 2014
The Lancet Respiratory Medicine article now published
30.12. 2013
The TRAUMAKINE consortium receives scientific advise from the EMA on the FP-1201-lyo clinical development
29.11. 2012
European commission has granted €6 million for Traumakine orphan program.